Clinical Trials on Intracranial Meningioma

Total 2215 results

NRG Oncology
National Cancer Institute (NCI)

Recruiting

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Intracranial Meningioma | Grade II Meningioma

Canada, United States, Japan, Saudi Arabia, India
SCRI Development Innovations, LLC
Novartis; Genentech, Inc.

Terminated

Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma

Intracranial Meningioma

United States
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...

Active, not recruiting

Multisession Radiosurgery in Large Meningiomas (MuRaLM)

Intracranial Meningioma

Italy
Chang Gung Memorial Hospital

Not yet recruiting

Cognition-preserving Brain Irradiation for Treating Patients With Intracranial Meningioma in the Era of Modern Radiotherapeutic Techniques Including Proton Beam Therapy - a Prospective Study Focusing on Radiological Outcomes and Neurocognitive Endpoints

Intracranial Meningioma

Taiwan
Assistance Publique Hopitaux De Marseille

Completed

Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas (CEVOREM)

Recurrent Meningiomas | Resistant Meningiomas

France
Assaf-Harofeh Medical Center

Unknown

Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery

Intracranial Meningioma | Neurologic Deficits

Israel
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); GlaxoSmithKline; Genentech, Inc.; Brain Science...

Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma | Recurrent Meningioma | NF2 Gene Mutation

United States
University Hospital, Montpellier
Centre Hospitalier Universitaire de Besancon

Recruiting

Oncological Care for Patients With Meningioma (ATYPICMENING)

Atypical Meningioma | Anaplastic Meningioma | Clear-cell Meningioma | Chordoid Meningioma | Rhabdoid Meningioma | Papillary Meningioma

France
Dana-Farber Cancer Institute
Bristol-Myers Squibb

Recruiting

An Open-Label Phase II Study of Nivolumab in Adult Participants With Progessive/ Recurrent Meningioma

Meningiomas

United States
Northwestern University
National Cancer Institute (NCI); NovoCure Ltd.

Recruiting

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Atypical Meningioma | Grade III Meningioma | Recurrent Meningioma | Anaplastic (Malignant) Meningioma | Grade II Meningioma | Supratentorial Meningioma

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Grade 1 Meningioma | Grade 2 Meningioma | Grade 3 Meningioma | Recurrent Meningioma | Unresectable Meningioma

United States
RenJi Hospital

Unknown

Effects of Scalp Nerve Blocks on Systemic Inflammation

Meningiomas

China
Kasr El Aini Hospital

Unknown

Cavernous Sinus Dissection and Bleeding in Meningiomas (OCS)

Meningiomas of the Middle Cranial Fossa

Egypt
Kasr El Aini Hospital

Unknown

Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial.

Neurocognitive Outcome Assesment in Patients With Perioptic Meningiomas
Emory University
National Cancer Institute (NCI)

Recruiting

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study (HiPPI)

Schwannoma | Grade III Meningioma | Intracranial Neoplasm | Nerve Sheath Neoplasm | Grade II Meningioma | Grade I Meningioma | Pituitary Gland Adenoma

United States
Nancy Ann Oberheim Bush, MD
Merck Sharp & Dohme LLC

Recruiting

Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

Recurrent Meningioma | Grade I Meningioma, Adult | Grade II Meningioma, Adult | Grade III Meningioma, Adult

United States
National Cancer Institute (NCI)

Recruiting

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

Grade 2 Meningioma | Grade 3 Meningioma | Recurrent Meningioma

United States
University of Nebraska
Chimerix

Not yet recruiting

A Study of ONC201 for Refractory Meningioma

Meningioma | Refractory Meningioma | Relapsed Meningioma

United States
Ohio State University

Recruiting

Cognitive Status After Removal of Skull Base Meningioma

Cognitive Impairment | Cognitive Decline | Meningioma | Skull Base Meningioma | Frontal Meningioma | Temporal Meningioma | Post-Surgical Cognition

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Predictive Factors for Survival in Aggressive Meningiomas (23Men)

Meningioma | Anaplastic Meningioma | Meningioma Atypical

Italy
National Cancer Institute (NCI)

Completed

Imatinib Mesylate in Treating Patients With Recurrent Meningioma

Recurrent Adult Brain Tumor | Adult Grade I Meningioma | Adult Grade II Meningioma | Adult Meningeal Hemangiopericytoma | Adult Meningioma | Adult Grade III Meningioma

United States
Tata Memorial Hospital
Terry Fox Foundation

Unknown

SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors (SCRT)

Craniopharyngioma | Meningiomas | Ependymomas | Low Grade Gliomas

India
Rabin Medical Center

Unknown

A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma

Hemangiopericytoma | Atypical Meningioma | Anaplastic Meningioma

Israel
Central Hospital, Nancy, France

Unknown

Study of the Inflammatory Microenvironment in Atypical Meningiomas

Atypical Meningioma

France
Colombian Foundation for Epilepsy and Neurological...

Unknown

Efficacy of Tranexamic Acid in Brain Tumor Resections (COLFIRE)

Neoplasms | Brain Tumors | Gliomas | Astrocytomas | Meningiomas

Colombia
University Hospital Heidelberg

Withdrawn

Comparison of Proton and Carbon Ion Radiotherapy With Advanced Photon Radiotherapy in Skull Base Meningiomas: The PINOCCHIO Trial. (PINOCCHIO)

Skull Base Meningioma

Germany
Central Hospital, Nancy, France
Institut National de la Santé Et de la Recherche Médicale, France

Recruiting

Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical Meningiomas (TransMenAtyp)

Meningioma Atypical

France
Central Hospital, Nancy, France

Completed

Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction (177Lumen)

Refractory Meningioma

France
Assiut University

Unknown

Sphenoorbital Meningioma Management.

Brain Meningioma
Fondation Ophtalmologique Adolphe de Rothschild

Recruiting

Predictive Factors of Visual Recovery After Paraoptic Tumors Removal (PRONOPTIC)

Tuberculum Sellae Meningioma

France
Xiangya Hospital of Central South University

Completed

Clinical Outcomes and Decision-making Choice of Skull Base Approaches for Petroclival Meningiomas

Skull Base Meningioma

China
Ethicon, Inc.
Guangzhou Bioseal Biotechnology Co., Ltd.

Completed

Phase IV Bioseal Study in Brain Tumor Surgery

Hemostasis | Meningioma Surgery

China
Istituto Oncologico Veneto IRCCS
Bayer

Not yet recruiting

Regorafenib for Recurrent Grade 2 and 3 Meningioma (MIRAGE Trial) (MIRAGE)

Meningioma, Malignant

Italy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...

Recruiting

Multisession Radiosurgery in Residual/Recurrent Grade II Meningiomas. (ATM)

Meningioma Atypical

Italy
Massachusetts General Hospital

Completed

Proton/Photon Rt - Benign Meningiomas(P92-13)

Benign Meningioma

United States
Washington University School of Medicine
Pfizer

Terminated

Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma

Meningioma | Meningioma, Adult

United States
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma

Adult Meningioma

United States
Beijing Tiantan Hospital

Recruiting

Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma

Meningioma, Malignant

China
Massachusetts General Hospital
Merck Sharp & Dohme LLC

Active, not recruiting

Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma

High Grade Meningioma

United States
Asan Medical Center
Samsung Medical Center; Pusan National University Hospital; Chonnam National... and other collaborators

Recruiting

Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON) ((ADD-ON))

Atrial Fibrillation | Acute Ischemic Stroke | Anticoagulant | Coronary Artery Atherosclerosis | Intracranial Atherosclerosis | Extracranial Atherosclerosis | Antiplatelet | Peripheral Artery Stenosis

Korea, Republic of
National Cancer Institute (NCI)

Completed

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Adult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain Tumor | Adult Grade I Meningioma | Adult Grade II Meningioma | Adult Grade III Meningioma

United States
European Organisation for Research and Treatment...
Novartis

Not yet recruiting

177Lu-DOTATATE for Recurrent Meningioma (LUMEN-1)

Recurrent Meningioma
Beijing Sanbo Brain Hospital

Recruiting

Apatinib in the Treatment of Recurrent Atypical/Malignant Meningioma in Adults

Recurrent Atypical/Malignant Meningioma

China
European Organisation for Research and Treatment...

Completed

Trabectedin for Recurrent Grade II/III Meningioma

Recurrent High Grade Meningioma

Belgium, Netherlands, France, Spain, Germany, United Kingdom, Italy, Norway, Switzerland, Austria
Centre Francois Baclesse
National Cancer Institute, France

Not yet recruiting

Long-term Cognitive and Functional Impact of Proton-therapy or Modern Fractionated Radiotherapy in Cavernous Sinus Meningioma: An Open-label Randomized 1:1 Phase III Study (COG-PROTON-01)

Cognitive Impairment | Cavernous Sinus Meningioma | Proton-therapy | Photon Radiotherapy

France
Second Affiliated Hospital, School of Medicine,...
Ningbo Medical Center Lihuili Hospital; Sir Run Run Shaw Hospital; Zhejiang Provincial... and other collaborators

Not yet recruiting

Efficacy of Postoperative Radiotherapy for Atypical Meningioma Without Venous Sinus Invasion After Gross-total Resection

Radiotherapy | Meningioma Atypical | Adverse Effect of Radiation Therapy | Progression-Free Survival
Lashmi Venkatraghavan
University Health Network, Toronto

Completed

Optic Nerve Sheath Diameter (ONSD) With the Raised PCO2 and Internal Jugular Venous Occlusion

Elevated Intracranial Pressure (ICP)

Canada
University Hospital, Toulouse

Completed

Assessment of Autonomic Neuronal Changes During Moderate Rise of Intracranial Pressure in Human (CESNA)

Increased Intracranial Pressure Disorders

France
IRCCS San Raffaele
Alleanza Contro il Cancro

Recruiting

Liquid Biopsy in High-grade Gliomas and Meningiomas (SOPRANO)

High Grade Glioma | High Grade Meningioma

Italy
Neonc Technologies, Inc.

Recruiting

NEO100 and High-Grade Meningioma

Residual, Progressive or Recurrent Grade II or III Meningioma

United States

Clinical Trials on Intracranial Meningioma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations